Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2780 Intracardiac Paragangliomas (PGLs): A Single-Institution Experience
Introduction: Intracardiac PGLs are extremely rare neuroendocrine tumors. There are few reported series in literature, indicating surgery as the most effective treatment modality.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Rossi M, Bora G, Lanza G, Meda S, Olivetti S,
Keywords: Intracardiac paraganglioma,
#2065 Sunitinib in Patients with Pre-Treated Pancreatic Neuroendocrine Tumors: A Real-World Study
Introduction: Besides data reported in a Phase-III trial, data on sunitinib in pancreatic Neuroendocrine Tumors (panNETs) are scanty.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Rinzivillo M
Authors: Rinzivillo M, Gritti S, Pusceddu S, Spallanzani A, Ibrahim T,
Keywords: Sunitinib, neuroendocrine tumors, pancreas, progressive disease, target therapy,
Introduction: In MEN1+ patients (MEN+), pNETs are considered to be high risk for multiple, malignant and aggressive tumors.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Chiloiro S
Authors: Chiloiro S, Bianchi A, Lanza F, Schinzari G, Bima C,
Introduction: Endocan has been reported as specific of endothelial tumor cells and was shown to be expressed by tip cells during the angiogenesis process.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Lugli F
Authors: Lugli F, Iacovazzo D, Lanza P, Inzani F, De Waure C,
Introduction: Pancreatic neuroendocrine tumors (pNETs) are often difficult to detect because of small size and have variable prognosis related to grading and staging.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Lanza F
Authors: Farchione A, Rufini V, Brizi M, Lanza F, Iacovazzo D,
Keywords: neuroendocrine tumors, MRI, DWI, PET,